COPD Drugs Lecture PDF Flashcards
Most common sources of acute exacerbation of COPD (4)
Single most important etiologic agent in development of COPD
- strep pneumoniae
- haemophilus influenzae
- mycoplasma pneumonaie
- influenza and adenovirus
-Chronic inhalation of tobacco smoke
2 effective drug classes for treatment of COPD
- inhaled B2 adrenergic agonists (short term or long acting)
- short acting antimuscarinic anticholinergic agents
Advantages of combo therapy of anticholinergics and B2 agonists in treatment of COPD (2)
- rapid onset of action and longer duration
- fewer side effects
What type of glucocorticoid has been seen to improve and reduce severity of COPD exacerbation?
Systemic - prednisone for example
Antibiotic treatment for COPD exacerbation
Based on local resistance patterns and initiated in patients whose sputum characteristics have changed, shown to be effective in decreasing short term mortality
Examples of antibiotic treatment in COPD (4)
- amoxicillin
- amoxicillin/clauvonic acid (augmentin)
- doxycycline (tetracycline)
- clarithromycin (macrolide)
Varenicline (Chantix) drug class and function
- Centrally acting nicotine receptor antagonist
- appears most effective agent for smoking cessation in long term treatment of COPD, exacerbations of mental illness with use have been reported
- Inhaled short acting bronchodilators in COPD patients treatment
- Inhaled long acting bronchodilators in COPD patients treatment
- Short acting use on regular basis not recommended, used for acute relief
- Regular lone treatment recommended for patients with moderate to severe dyspnea or increased risk of exacerbations
Inhaled corticosteroids and progression of COPD
They do NOT slow progression or reduce mortality of COPD, but improve symptoms less dramatically than in asthmatic patients, not recommended for use alone
Theophylline function in COPD
Not first line but can be tried in patients with persistent symptoms despite treatment with inhaled triple therapy
Triple therapy
LABA, LAMA, and an inhaled corticosteroid regimen for treatment of COPD
Rofluminast (Daliresp) durg class and function
- PO phosphodiesterase 4 inhibitor
- approved to reduce risk of exacerbations in adult patients with severe COPD associated with chronic bronchitis and history of exacerbations, not a bronchodilator
Rolfumilast (daliresp) ADR’s (2)
- N/V/D
- psychiatric effects
Azithromycin drug class and function in COPD
- macrolide antibiotic
- use once daily can reduce risk of exacerbation over one year and improve quality of life in patients with COPD at increased risk of exacerbation
Antianxiety and antidepressants in COPD treatment DOC and why? What should be avoided?
- Buspirone (Buspar) 5-10mg PO as it does not suppress ventilatory drive, does take SEVERAL weeks to become effective
- Benzodiazepines should be avoided